<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="99140">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01904058</url>
  </required_header>
  <id_info>
    <org_study_id>LUM001-201</org_study_id>
    <secondary_id>2013-000482-36</secondary_id>
    <nct_id>NCT01904058</nct_id>
  </id_info>
  <brief_title>Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis</brief_title>
  <acronym>CLARITY</acronym>
  <official_title>A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate LUM001, an Apical Sodium-dependent Bile Acid Transporter Inhibitor (ASBTi) in Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primary Biliary Cirrhosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lumena Pharmaceuticals, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lumena Pharmaceuticals, Inc.</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>United Kingdom: Medicines and Healthcare Products Regulatory Agency</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a randomized, double-blind, placebo-controlled, multicenter study. It is a
      13-week Phase 2 study in adults with primary biliary cirrhosis designed to compare the
      effect of daily dosing with UDCA in combination with LUM001 or placebo.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Efficacy</measure>
    <time_frame>13 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change from baseline in pruritus compared to placebo</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy</measure>
    <time_frame>13 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change from baseline in liver enzymes and other biochemical markers compared to placebo</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Safety and Tolerability</measure>
    <time_frame>13 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Evaluation of adverse events, changes in vital signs, laboratory and other safety parameters</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Primary Biliary Cirrhosis</condition>
  <condition>PBC</condition>
  <arm_group>
    <arm_group_label>LUM001 and Ursodeoxycholic Acid (UDCA)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administered orally once daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo and Ursodeoxycholic Acid (UDCA)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Administered orally once daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LUM001</intervention_name>
    <arm_group_label>LUM001 and Ursodeoxycholic Acid (UDCA)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo and Ursodeoxycholic Acid (UDCA)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ursodeoxycholic Acid</intervention_name>
    <arm_group_label>LUM001 and Ursodeoxycholic Acid (UDCA)</arm_group_label>
    <arm_group_label>Placebo and Ursodeoxycholic Acid (UDCA)</arm_group_label>
    <other_name>UDCA</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Diagnosis of Primary Biliary Cirrhosis

          2. Moderate to severe pruritus

          3. Taking ursodeoxycholic acid (UDCA) for at least 6 months, or unable to tolerate UDCA

          4. Ability to understand and willingness to sign informed consent prior to initiation of
             any study procedures

        Exclusion Criteria:

          1. History or presence of other concomitant significant liver disease

          2. Liver transplant

          3. Known HIV infection

          4. Women who are pregnant or lactating
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alejandro Dorenbaum, MD</last_name>
    <role>Study Director</role>
    <affiliation>Lumena Pharmaceuticals, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patricia Novak, PhD</last_name>
    <phone>858-461-0694</phone>
    <email>info@lumenapharma.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Scripps Clinic</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marjory Simpson</last_name>
      <phone>858-652-5420</phone>
      <email>simpson.marjory@scrippshealth.org</email>
    </contact>
    <investigator>
      <last_name>Paul Pockros, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California at Davis</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandeep Dhaliwal</last_name>
      <phone>916-734-8985</phone>
      <email>sandeep.dhaliwal@ucdmc.ucdavis.edu</email>
    </contact>
    <investigator>
      <last_name>Christopher Bowlus, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lia Quezada</last_name>
      <phone>305-243-6968</phone>
      <email>lquezada@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Cynthia Levy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monique Williams</last_name>
      <phone>773-702-4477</phone>
      <email>mwillia3@bsd.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Gautham Reddy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Limbach</last_name>
      <phone>317-278-9355</phone>
      <email>rlimbach@iu.edu</email>
    </contact>
    <investigator>
      <last_name>Raj Vuppalanchi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Hatter</last_name>
      <phone>502-852-3383</phone>
      <email>lisa.hatter@louisville.edu</email>
    </contact>
    <investigator>
      <last_name>Matthew Cave, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Baker</last_name>
      <phone>313-916-1979</phone>
      <email>kbaker@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Dilip Moonka, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Minnesota Gastroenterology</name>
      <address>
        <city>Plymouth</city>
        <state>Minnesota</state>
        <zip>55446</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leon Heller</last_name>
      <phone>612-870-5597</phone>
      <email>Leon.Heller@mngastro.com</email>
    </contact>
    <investigator>
      <last_name>Coleman Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Roberta Jorgensen</last_name>
      <phone>507-538-6547</phone>
      <email>jorgensen.roberta@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Nicholas LaRusso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Louis University</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorothy Heller</last_name>
      <phone>314-977-9389</phone>
      <email>dorothyheller@slu.edu</email>
    </contact>
    <investigator>
      <last_name>Bruce Bacon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Maier</last_name>
      <phone>646-962-5394</phone>
      <email>jam2078@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Sonal Kumar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Chason</last_name>
      <phone>214-648-2725</phone>
      <email>Rebecca.Chason@utsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Marlyn Mayo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Liver Therapies at St. Lukes Episcopal Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Dietrich</last_name>
      <phone>832-355-8966</phone>
      <email>bdietrich@stlukeshealth.org</email>
    </contact>
    <investigator>
      <last_name>John Vierling, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah Health Science Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiffany Tomkinson</last_name>
      <phone>801-585-9155</phone>
      <email>tiffany.tomkinson@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Juan Gallegos-Orozco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Liver Institute of Virginia</name>
      <address>
        <city>Newport News</city>
        <state>Virginia</state>
        <zip>23602</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzette Tipps</last_name>
      <phone>757-947-3190</phone>
      <email>suzette_tipps@bshsi.org</email>
    </contact>
    <investigator>
      <last_name>Mitchell Shiffman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hunter Holmes McGuire VA Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Salvatori</last_name>
      <phone>804-675-6924</phone>
      <email>jennifer.salvatori@va.gov</email>
    </contact>
    <investigator>
      <last_name>Velimir Luketic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington Harborview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carly Gintz</last_name>
      <phone>206-744-3479</phone>
      <email>cgintz@medicine.washington.edu</email>
    </contact>
    <investigator>
      <last_name>Charles Landis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>England</state>
        <zip>B15 2TT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Darren Barton</last_name>
      <phone>44 (0) 121 414 8255</phone>
      <email>d.barton@bham.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Gideon Hirschfield, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Liverpool &amp; Broadgreen University Hospital</name>
      <address>
        <city>Liverpool</city>
        <state>England</state>
        <zip>L7 8XP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kate Martin</last_name>
      <phone>0151 706 4194</phone>
      <email>Kate.Martin@rlbuht.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Imran Patanwala, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Newcastle University</name>
      <address>
        <city>Newcastle</city>
        <state>England</state>
        <zip>NE1 4LP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Bainbridge</last_name>
      <phone>0191 282 0070</phone>
      <email>j.m.bainbridge@newcastle.ac.uk</email>
    </contact>
    <investigator>
      <last_name>David Jones, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oxford University Hospitals</name>
      <address>
        <city>Oxford</city>
        <state>England</state>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madeleine Thyssen</last_name>
      <phone>01865 231618</phone>
      <email>Endoscopy.researchsisters@orh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Roger Chapman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Imperial College London St Mary's Hospital</name>
      <address>
        <city>London</city>
        <zip>W2 1NY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louise Campbell</last_name>
      <phone>020 3312 1649</phone>
      <email>louise.campbell@imperial.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Mark Thursz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.lumenapharma.com</url>
  </link>
  <verification_date>June 2014</verification_date>
  <lastchanged_date>June 2, 2014</lastchanged_date>
  <firstreceived_date>July 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PBC</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Liver Cirrhosis, Biliary</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ursodeoxycholic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
